These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21198566)

  • 1. The effect of prophylactic medications on TMS for migraine aura.
    Almaraz AC; Dilli E; Dodick DW
    Headache; 2010 Nov; 50(10):1630-3. PubMed ID: 21198566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
    Young W; Shaw J; Bloom M; Gebeline-Myers C
    Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gap junctional intercellular communication: a new mechanism in pathophysiology of migraine with aura. Therapeutic applications].
    Sarrouilhe D; Dejean C
    Pathol Biol (Paris); 2012 Dec; 60(6):392-8. PubMed ID: 22633071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine with and without aura: electrophysiological and functional neuroimaging evidence.
    Bramanti P; Grugno R; Vitetta A; Di Bella P; Muscarà N; Nappi G
    Funct Neurol; 2005; 20(1):29-32. PubMed ID: 15948565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are cortical spreading depression and headache in migraine causally linked?
    Wolthausen J; Sternberg S; Gerloff C; May A
    Cephalalgia; 2009 Feb; 29(2):244-9. PubMed ID: 19025548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of migraine with aura and cortical spreading depression from 1941 and onwards.
    Tfelt-Hansen PC
    Cephalalgia; 2010 Jul; 30(7):780-92. PubMed ID: 19740119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy.
    Palermo A; Fierro B; Giglia G; Cosentino G; Puma AR; Brighina F
    Neurosci Lett; 2009 Dec; 467(1):26-9. PubMed ID: 19800389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study.
    Tulunay FC; Ergün H; Gülmez SE; Ozbenli T; Ozmenoğlu M; Boz C; Erdemoglu AK; Varlikbas A; Göksan B; Inan L
    Funct Neurol; 2004; 19(3):197-202. PubMed ID: 15595715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
    Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
    Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible precipitation of migraine attacks with prophylactic treatment.
    Donnet A; Vuillaume De Diego E; Lanteri-Minet M
    Eur Neurol; 2009; 61(1):23-6. PubMed ID: 18948696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of migraine with aura: comments and perspectives.
    D'Andrea G; Bonavita V; Rigamonti A; Bussone G
    Neurol Sci; 2003 Feb; 23(6):271-8. PubMed ID: 12624713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study.
    Hauge AW; Asghar MS; Schytz HW; Christensen K; Olesen J
    Lancet Neurol; 2009 Aug; 8(8):718-23. PubMed ID: 19570717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency transcranial magnetic stimulation on motor cortex of patients affected by migraine with aura: a way to restore normal cortical excitability?
    Brighina F; Palermo A; Daniele O; Aloisio A; Fierro B
    Cephalalgia; 2010 Jan; 30(1):46-52. PubMed ID: 19438928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
    Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial direct current stimulation reveals inhibitory deficiency in migraine.
    Chadaide Z; Arlt S; Antal A; Nitsche MA; Lang N; Paulus W
    Cephalalgia; 2007 Jul; 27(7):833-9. PubMed ID: 17498207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cortical excitability in chronic migraine (transformed migraine) and migraine without aura. A transcranial magnetic stimulation study.
    Ozturk V; Cakmur R; Donmez B; Yener GG; Kursad F; Idiman F
    J Neurol; 2002 Sep; 249(9):1268-71. PubMed ID: 12242552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.
    Brighina F; Palermo A; Aloisio A; Francolini M; Giglia G; Fierro B
    Clin Neuropharmacol; 2006; 29(6):338-42. PubMed ID: 17095897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-pulse transcranial magnetic stimulation: a new way to treat migraine attacks with aura.
    Diener HC
    Lancet Neurol; 2010 Apr; 9(4):335-7. PubMed ID: 20206580
    [No Abstract]   [Full Text] [Related]  

  • 19. Peri-ictal changes of cortical excitability in children suffering from migraine without aura.
    Siniatchkin M; Reich AL; Shepherd AJ; van Baalen A; Siebner HR; Stephani U
    Pain; 2009 Dec; 147(1-3):132-40. PubMed ID: 19796876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
    Afridi SK; Giffin NJ; Kaube H; Goadsby PJ
    Neurology; 2013 Feb; 80(7):642-7. PubMed ID: 23365053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.